SUMMARY Polyclonal rat antisera, raised against affinity purified CD3 antigen, gave strong immunoenzymatic labelling of T cells in routine paraffin embedded sections, with negligible background staining. The specificity of these reactions was confirmed by staining biopsy specimens from 21 previously phenotyped non-Hodgkin's lymphomas (including 14 of T cell origin and six of B cell origin). It is suggested that the ability of the polyclonal anti-CD3 antisera to detect T cells in paraffin sections is due to the presence in these sera of antibodies against fixation resistant epitopes on CD3 antigen, and that immunisation with purified denatured preparations of other white cell associated antigens may broaden the range of antibodies suitable for the phenotypic analysis of leucocytes in routine histological samples.
The production of monoclonal antibodies has led to the identification of several antigenic molecules associated with different white cell lineages (such as T cells, and B cells).' These cellular markers (many of which are now well characterised at both the biochemical and DNA level) have proved of great value in clinical research; they allow white cell populations and their functions to be studied with a high degree of precision. Furthermore, many laboratories now routinely use monoclonal antibodies against human white cell antigens for the diagnosis and the characterisation of leukaemias and lymphomas.
Despite the clinical usefulness of white cell antigens a major obstacle to their wider exploitation remains in that most do not survive tissue processing-that is, formalirn fixation and paraffin embedding-in a form which is detectable by most monoclonal antibodies currently available. Therefore it is usually only possible to detect white cell antigens when living cells, fresh cell smears, or sections of frozen tissue are available.
In this paper we describe the use of polyclonal antisera raised against purified denatured T3 (CD3) antigen to detect reactive and neoplastic T cells in routinely processed lymphoid tissue samples. The ability to detect this well characterised T cellassociated molecule in such material opens up the Accepted for publication 26 with minimal non-specific background staining. The ability to identify normal and neoplastic T cells specifically in paraffin sections is of considerable practical importance for two reasons. Firstly, the morphological preservation of cellular detail in this type of material is clearly superior to that seen in cryostat sections. Consequently it may now be possible to undertake immunohistological studies which have previously been hampered by the poor preservation of morphological detail in cryostat sections (such as on the T cell nature of Reed Stemnberg cells). Secondly, the possibility arises of extensive retrospective studies of reactive and neoplastic T cell populations in stored tissue blocks. There have been several reports of monoclonal antibodies capable of detecting T cells in routinely processed paraffin embedded tissue.8'3 The best characterised of these reagents (in terms of the target antigen) is antibody UCHL1, which recognises the T cell-associated variant of the leucocyte common antigen.894 Although the antibody reacts with most T cells, it also recognises a minor population of B cells (and also some histiocytes). In keeping with this pattern of reactivity, it has been shown to detect not only most T cell lymphomas, but also some B cell neoplasms.912 Another reagent which may be similar to UCHLI is monoclonal antibody MTI, which was reported by the laboratory from which it originated to recognise a 190 kD antigen." 3 Although this molecular weight is appropriate for the T cellassociated variant of the leucocyte common antigen, antibody MTI (unlike UCHLI) has not been investigated in any ofthe workshops on leucocyte differentiation antigens and its specificity for this molecule remains unproved, but it resembles antibody UCHLI in that it reacts with proportion of B cell neoplasms."
In contrast to these reagents, the polyclonal antisera reported in the present paper react with an antigen 124 Detection ofreactive and neoplastic T cells in paraffin embedded biopsy specimens (CD3) which in the course of extensive analyses has never been found on B cells. The antigen was first detected more than seven years ago and was given the designation CD3 at the first international workshop on human leucocyte differentiation antigens in 1983,'5 although it is also widely referred to as "T3 antigen", after the name of the first reported monoclonal anti-CD3 antibody. '6 The CD3 antigen seems to be unique to the T cell lineage. The only possible exception is its reported weak expression in Purkinje cells in the brain'7; but within haemopoietic and lymphoid tissue there is no evidence for the molecule's existence on any cells other that those of T lymphoid origin. It appears early in T cell maturation, initially within the perinuclear space (at the precortical thymocyte stage)'8 and then subsequently, in post-cortical T cells in the cell surface membrane. It has been suggested that the appearance of small amounts of intracellular CD3 indicates the earliest sign ofcommittment to the T cell lineage. 9 The T cell lymphomas in this study, in which CD3 antigen appeared to be localised around the cell nucleus, may therefore have arisen from early stages of T cell maturation (while the case showing probable CD3 inclusion bodies may reflect a block in the insertion of the antigen in the surface membrane).
Biochemical studies have shown that the CD3 antigen consists of at least three polypeptide chains. These are designated y, 6, and E, having molecular weights of 26, 21, and 19 kD respectively.?"2' Genes coding for each of these chains have now been identified,7 22 23 and it is evident that whereas the y and 6 chains show considerable homology to each other in their amino acid sequences, the E chain shows a much more remote association.7 Additional chains in the human CD3 complex may also be recognised as the T3 antigen in mice apparently comprises at least five different polypeptide chains-that is, three chains equivalent to the human y, 6, and £ chains, plus additional 21 and 16 kD chains.24 There has been a recent report claiming to identify the human equivalent of the 16 kD chain.25 The CD3 polypeptide chains are closely associated in the T cell membrane not only with each other, but also with the T cell antigen receptor. 26 It is likely that CD3 plays a crucial part in the response of T cells to antigenic stimuli by delivering a biochemical signal to the cell interior following binding of antigen to the receptor.25 In this context it may be of relevance that stimulation of T cells by specific antigen, polyclonal mitogens, or phorbol ester causes rapid selective phosphorylation, especially of the y chain of the CD3 complex.2728
Previous studies of fresh cell and tissue samples have indicated that the CD3 antigen is present on many T cell neoplasms.'7213' In keeping with the fact that it is initially an internal cell constituent its demonstration in leukaemias and lymphomas of thymic phenotype requires a technique which shows intracellular antigen, such as staining of cytospin preparations or tissue sections.32 In the present study this phenomenon is probably epitomised by the lymphoblastic lymphoma (case 9) which was CD3 negative when tested in cell suspension, but strongly positive when stained in paraffin sections.
The specificity of the CD3 antigen for the T cell lineage and its appearance very early in T cell maturation make it an obvious candidate as an optimal pan-T marker for detecting T cell neoplasms. No laboratories, however, have previously convincingly shown that the antigen can be detected reliably in formalin fixed paraffin embedded tissue. It must therefore be concluded that most, if not all, existing monoclonal anti-CD3 antibodies recognise epitopes which are destroyed by tissue processing. In keeping with this we have found, when screening 20 antibodies of this specificity from the third international workshop on human leucocyte differentiation antigens, that none of these reagents was capable of staining routinely processed paraffin embedded lymphoid tissue.
The strong labelling for CD3 obtained in the present study suggests that the polyclonal CD3 antisera contained antibodies directed against epitopes of the CD3 complex resistant to denaturation. It may be relevant that the antisera were raised against isolated CD3 chains which had been purified from lymphocyte membranes by immunoaffinity chromatography and subsequent elution after SDS-PAGE of the purified antigen. The antisera thus differ from existing monoclonal CD3 antibodies, most, if not all, of which were raised against living or lightly fixed T cells. Exposure of the CD3 antigen to denaturing agents (high pH, SDS) during its isolation may expose or induce epitopes which are not found in the native molecule, but which are present in formalin fixed tissue sections. In this case a proportion of the anti-CD3 antibodies in the polyclonal antisera would be expected to recognise these epitopes. This hypothesis is supported by the fact that the anti-CD3 antisera gave strong reactions by Western blotting as well as on paraffin sections but showed negligible reactivity when tested against living T cells (in which all epitopes would be in the native conformation) (Krissansen G, unpublished observation). This discrepancy might also be accounted for, at least in part, by the presence in the polyclonal antisera of a predominance of antibodies specific for intracytoplasmic portions of the CD3 polypeptides (which would not be accessible on the surface of whole cells).
While the antiserum raised against the denatured 6 chain recognised this chain, it also possessed a strong reactivity with the £ chain. Furthermore, as the anti-18 kD serum is specific for the 18 kD and E chains, the 126 Mason, Krissansen, Davey, Crumpton, Gatter epitope(s) resistant to denaturation are probably an inherent feature of the a chain. Interestingly, the cytoplasmic domain of the E chain would be anticipated to possess an unfolded structure as it is rich in glycine and proline residues and likely to be relatively resistant to denaturation.
Finally, the present study is of potentially much wider relevance than in the context of CD3 antigen alone, as it raises the possibility of detecting denaturation resistant epitopes on other well characterised molecules specific for different white cell lineages-for example, CD4, CD5, CD8, CDl9, CD22, etc-and thereby greatly widening the scope of immunocytochemistry in the study of routine histological material. This is particularly relevant in the typing of T cell neoplasms as CD3, although a reliable member of early T cells, is absent on up to 20% of post-thymic T cell lymphomas.303'33 An effective strategy for the production of such reagents is likely to be immunisation of animals with purified antigen that has been deliberately denatured during isolation so as to increase the likelihood of producing antibodies against determinants which resist tissue processing. It will also be ofvalue to produce monoclonal antibodies which duplicate the specificity of the polyclonal anti-CD3 antisera described in this paper. This would ensure the reproducibility of reagents for detecting CD3 in routine biopsy specimens, facilitate their large scale production, and avoid the weak non-specific staining reactions-for example, of squamous epithelium-associated with the present polyclonal antisera. 
